Literature DB >> 29937979

Development of Highly Potent and Selective Steroidal Inhibitors and Degraders of CDK8.

John M Hatcher1,2, Eric S Wang1,2, Liv Johannessen1,2, Nicholas Kwiatkowski1,2, Taebo Sim3, Nathanael S Gray1,2.   

Abstract

Cortistatin A is a natural product isolated from the marine sponge Corticium simplex and was found to be a potent and selective inhibitor of CDK8. Many synthetic groups have reported total syntheses of Cortistatin A; however, these syntheses require between 16 and 30 steps and report between 0.012-2% overall yields, which is not amenable to large-scale production. Owing to similarities between the complex core of Cortistatin A and the simple steroid core, we initiated a campaign to design simple, more easily prepared CDK8 inhibitors based on a steroid scaffold that would be more convenient for large-scale synthesis. Herein, we report the discovery and optimization of JH-VIII-49, a potent and selective inhibitor of CDK8 with a simple steroid core that has an eight-step synthesis with a 33% overall yield, making it suitable for large-scale preparation. Using this scaffold, we then developed a bivalent small molecule degrader, JH-XI-10-02, that can recruit the E3 ligase CRL4Cereblon to promote the ubiquitination and proteosomal degradation of CDK8.

Entities:  

Year:  2018        PMID: 29937979      PMCID: PMC6004574          DOI: 10.1021/acsmedchemlett.8b00011

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  32 in total

1.  CDK8 is a stimulus-specific positive coregulator of p53 target genes.

Authors:  Aaron Joseph Donner; Stephanie Szostek; Jennifer Michelle Hoover; Joaquin Maximiliano Espinosa
Journal:  Mol Cell       Date:  2007-07-06       Impact factor: 17.970

2.  Enantioselective synthesis of (+)-cortistatin a, a potent and selective inhibitor of endothelial cell proliferation.

Authors:  Hong Myung Lee; Cristina Nieto-Oberhuber; Matthew D Shair
Journal:  J Am Chem Soc       Date:  2008-12-17       Impact factor: 15.419

3.  The human CDK8 subcomplex is a histone kinase that requires Med12 for activity and can function independently of mediator.

Authors:  Matthew T Knuesel; Krista D Meyer; Aaron J Donner; Joaquin M Espinosa; Dylan J Taatjes
Journal:  Mol Cell Biol       Date:  2008-12-01       Impact factor: 4.272

Review 4.  CDK8: a positive regulator of transcription.

Authors:  Matthew D Galbraith; Aaron J Donner; Joaquín M Espinosa
Journal:  Transcription       Date:  2010 Jul-Aug

Review 5.  Involvement of Mediator complex in malignancy.

Authors:  Concetta Schiano; Amelia Casamassimi; Monica Rienzo; Filomena de Nigris; Linda Sommese; Claudio Napoli
Journal:  Biochim Biophys Acta       Date:  2013-12-14

6.  Srb10/Cdk8 regulates yeast filamentous growth by phosphorylating the transcription factor Ste12.

Authors:  Chris Nelson; Susan Goto; Karen Lund; Wesley Hung; Ivan Sadowski
Journal:  Nature       Date:  2003-01-09       Impact factor: 49.962

7.  Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover.

Authors:  Christy J Fryer; J Brandon White; Katherine A Jones
Journal:  Mol Cell       Date:  2004-11-19       Impact factor: 17.970

8.  Identification of Mediator Kinase Substrates in Human Cells using Cortistatin A and Quantitative Phosphoproteomics.

Authors:  Zachary C Poss; Christopher C Ebmeier; Aaron T Odell; Anupong Tangpeerachaikul; Thomas Lee; Henry E Pelish; Matthew D Shair; Robin D Dowell; William M Old; Dylan J Taatjes
Journal:  Cell Rep       Date:  2016-03-31       Impact factor: 9.423

9.  Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation.

Authors:  Calla M Olson; Baishan Jiang; Michael A Erb; Yanke Liang; Zainab M Doctor; Zinan Zhang; Tinghu Zhang; Nicholas Kwiatkowski; Myriam Boukhali; Jennifer L Green; Wilhelm Haas; Tyzoon Nomanbhoy; Eric S Fischer; Richard A Young; James E Bradner; Georg E Winter; Nathanael S Gray
Journal:  Nat Chem Biol       Date:  2017-12-18       Impact factor: 16.174

Review 10.  Drugging the undruggables: exploring the ubiquitin system for drug development.

Authors:  Xiaodong Huang; Vishva M Dixit
Journal:  Cell Res       Date:  2016-03-22       Impact factor: 25.617

View more
  15 in total

Review 1.  PROTACs: great opportunities for academia and industry.

Authors:  Xiuyun Sun; Hongying Gao; Yiqing Yang; Ming He; Yue Wu; Yugang Song; Yan Tong; Yu Rao
Journal:  Signal Transduct Target Ther       Date:  2019-12-24

2.  Optical Control of Small Molecule-Induced Protein Degradation.

Authors:  Yuta Naro; Kristie Darrah; Alexander Deiters
Journal:  J Am Chem Soc       Date:  2020-01-23       Impact factor: 15.419

3.  Potent and Preferential Degradation of CDK6 via Proteolysis Targeting Chimera Degraders.

Authors:  Shang Su; Zimo Yang; Hongying Gao; Haiyan Yang; Songbiao Zhu; Zixuan An; Juanjuan Wang; Qing Li; Sarat Chandarlapaty; Haiteng Deng; Wei Wu; Yu Rao
Journal:  J Med Chem       Date:  2019-08-02       Impact factor: 7.446

4.  Mutant-Selective Allosteric EGFR Degraders are Effective Against a Broad Range of Drug-Resistant Mutations.

Authors:  Jaebong Jang; Ciric To; Dries J H De Clercq; Eunyoung Park; Charles M Ponthier; Bo Hee Shin; Mierzhati Mushajiang; Radosław P Nowak; Eric S Fischer; Michael J Eck; Pasi A Jänne; Nathanael S Gray
Journal:  Angew Chem Int Ed Engl       Date:  2020-07-09       Impact factor: 15.336

Review 5.  Bivalent Ligands for Protein Degradation in Drug Discovery.

Authors:  Marcel Scheepstra; Koen F W Hekking; Luc van Hijfte; Rutger H A Folmer
Journal:  Comput Struct Biotechnol J       Date:  2019-01-25       Impact factor: 7.271

Review 6.  Regulatory functions of the Mediator kinases CDK8 and CDK19.

Authors:  Charli B Fant; Dylan J Taatjes
Journal:  Transcription       Date:  2018-12-26

Review 7.  Therapeutic targeting of transcriptional cyclin-dependent kinases.

Authors:  Matthew D Galbraith; Heather Bender; Joaquín M Espinosa
Journal:  Transcription       Date:  2018-11-09

Review 8.  Targeting Protein Kinases Degradation by PROTACs.

Authors:  Fei Yu; Ming Cai; Liang Shao; Jihong Zhang
Journal:  Front Chem       Date:  2021-06-30       Impact factor: 5.221

9.  A kinase-independent role for CDK8 in BCR-ABL1+ leukemia.

Authors:  Ingeborg Menzl; Tinghu Zhang; Angelika Berger-Becvar; Reinhard Grausenburger; Gerwin Heller; Michaela Prchal-Murphy; Leo Edlinger; Vanessa M Knab; Iris Z Uras; Eva Grundschober; Karin Bauer; Mareike Roth; Anna Skucha; Yao Liu; John M Hatcher; Yanke Liang; Nicholas P Kwiatkowski; Daniela Fux; Andrea Hoelbl-Kovacic; Stefan Kubicek; Junia V Melo; Peter Valent; Thomas Weichhart; Florian Grebien; Johannes Zuber; Nathanael S Gray; Veronika Sexl
Journal:  Nat Commun       Date:  2019-10-18       Impact factor: 14.919

Review 10.  PROTACs: great opportunities for academia and industry.

Authors:  Xiuyun Sun; Hongying Gao; Yiqing Yang; Ming He; Yue Wu; Yugang Song; Yan Tong; Yu Rao
Journal:  Signal Transduct Target Ther       Date:  2019-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.